Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Health Canada has approved FLUAD, a Novartis seasonal flu vaccine for adults 65 years and older. Canadian seniors are the hardest hit of all age groups by seasonal influenza and account for 90 per cent of influenza deaths and 70 per cent of hospitalizations.

22 Feb 2011

Study: Early detection of hearing impairment may prevent chronic disease in middle-aged adults

Several factors may be associated with hearing impairment in middle-aged adults, including cardiovascular disease risks, being male and having a noisy job, according to a report published online first in the Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. The paper will be appear in the May print issue of the journal.

22 Feb 2011

Research: Blood and hormone level in saliva can reveal burnout symptoms

Your blood and the level of a hormone in your spit could reveal if you're on the point of burnout, according to research undertaken by Dr. Sonia Lupien and Robert-Paul Juster of the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital and the University of Montreal.

22 Feb 2011

Study: Gender may not increase risk of heart attack deaths

A study led by the University of Michigan Cardiovascular Center shows being a woman may not increase your risk of dying from treatment for a severe heart attack.

21 Feb 2011

CIGNA, Healthy Kids Challenge launch new online initiative to help reverse obesity trend

CIGNA and Healthy Kids Challenge, working together since 2004 to fight obesity, today announced the launch of their latest initiative - an online CIGNA Mix Six for Healthy Balance Toolkit offering real-life ways for individuals, families and employers to incorporate better health into their daily routines.

21 Feb 2011

Lifestyle therapy program may help manage cardiovascular risk factors

Two/thirds of adults with high cholesterol and half with high blood pressure are not being treated effectively for these conditions, according to a recent announcement by the Centers for Disease Control and Prevention (CDC). This disturbing data spotlights the crucial need for new solutions to reduce the risk factors that are behind the current epidemic of chronic illness in the U.S.

21 Feb 2011

In the Gulf states rates of heart disease are rising with the economy

Rapid improvement in the socio-economic conditions of the Gulf states has been followed by lifestyle changes now contributing to high rates of cardiovascular disease. Professor Hani Najm, President of the Saudi Heart Association whose annual conference begins 21 February 2011, describes risk factor prevalence rates as "extremely high", particularly in the cities of Saudi Arabia.

20 Feb 2011

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate. Sustained or further improvements were observed across all endpoints, including bone disease, at the three-year timepoint.

19 Feb 2011

Cintas commits fundraising for AHA programs to promote heart health awareness

In recognition of American Heart Month, Cintas Corporation today announced it has committed to fundraising for the American Heart Association, as part of its First Aid & Safety Division's efforts to raise awareness about heart health.

19 Feb 2011

USPTO issues two patents to VIRxSYS SMaRT RNA platform technology

VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.

18 Feb 2011

Emotional response to challenging situations predict body's response to stress

Your emotional response to challenging situations could predict how your body responds to stress, according to research published this month in the journal Brain, Behavior, and Immunity.

18 Feb 2011

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.

18 Feb 2011

West Virginia receives $186,000 AstraZeneca grant to expand Cardiovascular Health program

The AstraZeneca HealthCare Foundation program, Connections for Cardiovascular Health, today announced a grant of more than $186,000 to West Virginia Health Right, Inc. in Charleston to expand the Pathways to Cardiovascular Health program.

17 Feb 2011

FDA clears Toshiba's Auto-IMT ultrasound software tool

For physicians, the ability to streamline exams for determining a patient's risk for cardiovascular disease is important in determining the patient's clinical pathway. To enhance diagnostic efficiency, Toshiba America Medical Systems, Inc. has introduced Auto-IMT, an ultrasound software tool that can measure the thickness of the intima-media layers of the carotid artery, for evaluating an asymptomatic patient's risk of developing cardiovascular disease.

16 Feb 2011

ACC releases CardioSmart 'Survival Guides' for five common heart problems

In recognition of American Heart Month, the American College of Cardiology today released CardioSmart "Survival Guides" for five of the most common heart problems: coronary artery disease, heart failure, arrhythmia, hypertension and heart attack.

16 Feb 2011

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

The World Heart Federation, sanofi-aventis and Boehringer Ingelheim have announced their collaboration on the AF AWARE campaign today, to raise awareness of atrial fibrillation (AF) and its links to severe consequences including cardiovascular mortality, stroke and CV hospitalizations.

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

Sanofi-aventis enters definitive agreement to acquire Genzyme

Sanofi-aventis and Genzyme Corporation announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion.

16 Feb 2011

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.

16 Feb 2011

Research: Way heart responds to early beat is predictive of cardiac death

The way the heart responds to an early beat is predictive of cardiac death, especially for people with no conventional markers of cardiovascular disease, according to new research from Washington University School of Medicine in St. Louis.

16 Feb 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Study: Early detection of hearing impairment may prevent chronic disease in middle-aged adults

Research: Blood and hormone level in saliva can reveal burnout symptoms

Study: Gender may not increase risk of heart attack deaths

CIGNA, Healthy Kids Challenge launch new online initiative to help reverse obesity trend

Lifestyle therapy program may help manage cardiovascular risk factors

In the Gulf states rates of heart disease are rising with the economy

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Cintas commits fundraising for AHA programs to promote heart health awareness

USPTO issues two patents to VIRxSYS SMaRT RNA platform technology

Emotional response to challenging situations predict body's response to stress

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

West Virginia receives $186,000 AstraZeneca grant to expand Cardiovascular Health program

FDA clears Toshiba's Auto-IMT ultrasound software tool

ACC releases CardioSmart 'Survival Guides' for five common heart problems

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Sanofi-aventis enters definitive agreement to acquire Genzyme

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Research: Way heart responds to early beat is predictive of cardiac death

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in